Nicholas Wealth LLC. Takes $2.02 Million Position in Oscar Health, Inc. $OSCR

Nicholas Wealth LLC. purchased a new stake in shares of Oscar Health, Inc. (NYSE:OSCR) during the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor purchased 106,467 shares of the company’s stock, valued at approximately $2,015,000. Oscar Health accounts for about 0.8% of Nicholas Wealth LLC.’s holdings, making the stock its 28th largest holding.

A number of other institutional investors also recently bought and sold shares of the stock. LRI Investments LLC raised its position in shares of Oscar Health by 377.9% in the 2nd quarter. LRI Investments LLC now owns 1,233 shares of the company’s stock worth $26,000 after acquiring an additional 975 shares in the last quarter. Farther Finance Advisors LLC raised its holdings in Oscar Health by 4,420.7% in the third quarter. Farther Finance Advisors LLC now owns 1,311 shares of the company’s stock worth $25,000 after purchasing an additional 1,282 shares in the last quarter. Atlantic Union Bankshares Corp purchased a new stake in shares of Oscar Health during the second quarter valued at about $33,000. Jones Financial Companies Lllp lifted its position in Oscar Health by 7,473.3% during the first quarter. Jones Financial Companies Lllp now owns 2,272 shares of the company’s stock valued at $30,000 after acquiring an additional 2,242 shares during the last quarter. Finally, Strs Ohio purchased a new stake in Oscar Health during the first quarter valued at approximately $30,000. 75.70% of the stock is currently owned by institutional investors.

Insider Transactions at Oscar Health

In other Oscar Health news, insider Mario Schlosser sold 38,835 shares of the stock in a transaction that occurred on Wednesday, December 24th. The stock was sold at an average price of $15.00, for a total transaction of $582,525.00. Following the completion of the transaction, the insider owned 438,348 shares of the company’s stock, valued at $6,575,220. This represents a 8.14% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, insider Janet Liang sold 7,338 shares of Oscar Health stock in a transaction that occurred on Tuesday, December 2nd. The stock was sold at an average price of $16.59, for a total value of $121,737.42. Following the completion of the sale, the insider directly owned 172,527 shares in the company, valued at $2,862,222.93. This represents a 4.08% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders have sold a total of 383,307 shares of company stock valued at $5,919,555 in the last 90 days. Corporate insiders own 25.11% of the company’s stock.

Analyst Upgrades and Downgrades

A number of equities analysts have recently issued reports on OSCR shares. Wall Street Zen downgraded Oscar Health from a “hold” rating to a “sell” rating in a research report on Saturday, December 6th. Barclays upped their price objective on shares of Oscar Health from $11.00 to $13.00 and gave the company an “underweight” rating in a report on Monday, November 10th. Weiss Ratings reaffirmed a “sell (d)” rating on shares of Oscar Health in a report on Wednesday, October 8th. Piper Sandler upgraded Oscar Health from a “neutral” rating to an “overweight” rating and boosted their price target for the company from $13.00 to $25.00 in a research note on Tuesday, November 25th. Finally, The Goldman Sachs Group started coverage on Oscar Health in a report on Tuesday, October 14th. They issued a “neutral” rating and a $17.00 price objective on the stock. One research analyst has rated the stock with a Buy rating, six have assigned a Hold rating and four have given a Sell rating to the stock. According to MarketBeat.com, the stock presently has an average rating of “Reduce” and a consensus price target of $15.57.

Oscar Health Stock Down 0.2%

OSCR stock opened at $14.50 on Wednesday. The firm’s fifty day moving average is $16.31 and its 200 day moving average is $17.08. The firm has a market cap of $3.84 billion, a PE ratio of -12.94 and a beta of 1.88. Oscar Health, Inc. has a one year low of $11.20 and a one year high of $23.80. The company has a debt-to-equity ratio of 0.67, a quick ratio of 0.92 and a current ratio of 0.92.

Oscar Health (NYSE:OSCR) last posted its earnings results on Thursday, November 6th. The company reported ($0.53) EPS for the quarter, beating analysts’ consensus estimates of ($0.55) by $0.02. The firm had revenue of $2.93 billion for the quarter, compared to analysts’ expectations of $3.09 billion. Oscar Health had a negative return on equity of 21.50% and a negative net margin of 2.16%.The company’s quarterly revenue was up 23.2% on a year-over-year basis. During the same period last year, the firm earned ($0.22) EPS. On average, research analysts forecast that Oscar Health, Inc. will post 0.69 EPS for the current year.

Oscar Health Profile

Oscar Health, trading on the New York Stock Exchange under the ticker OSCR, is a technology-driven health insurance company headquartered in New York, New York. Founded in 2012 by Mario Schlosser, Joshua Kushner and Kevin Nazemi, the company was built with the goal of simplifying healthcare coverage and enhancing member experience. Oscar leverages a proprietary digital platform to streamline plan enrollment, claims administration and member support, distinguishing itself in the individual, family and small group insurance markets.

The company’s primary products include on-exchange individual and family medical plans under the Affordable Care Act, off-exchange plans, as well as Medicare Advantage offerings.